TrialAnnals of oncology : official journal of the European Society for Medical Oncology2019

De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study.

V Guarneri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.